Author:
Coates A.S.,Winer E.P.,Goldhirsch A.,Gelber R.D.,Gnant M.,Piccart-Gebhart M.,Thürlimann B.,Senn H.-J.,André Fabrice,Baselga José,Bergh Jonas,Bonnefoi Hervé,Burstein Harold,Cardoso Fatima,Castiglione-Gertsch Monica,Coates Alan S.,Colleoni Marco,Curigliano Giuseppe,Davidson Nancy E.,Di Leo Angelo,Ejlertsen Bent,Forbes John F.,Galimberti Viviana,Gelber Richard D.,Gnant Michael,Goldhirsch Aron,Goodwin Pamela,Harbeck Nadia,Hayes Daniel F.,Huober Jens,Hudis Clifford A.,Ingle James N.,Jassem Jacek,Jiang Zefei,Karlsson Per,Morrow Monica,Orecchia Roberto,Kent Osborne C.,Partridge Ann H.,de la Peña Lorena,Piccart-Gebhart Martine J.,Pritchard Kathleen I.,Rutgers Emiel J.T.,Sedlmayer Felix,Semiglazov Vladimir,Shao Zhi-Ming,Smith Ian,Thürlimann Beat,Toi Masakazu,Tutt Andrew,Viale Giuseppe,von Minckwitz Gunter,Watanabe Toru,Whelan Timothy,Winer Eric P.,Xu Binghe
Reference116 articles.
1. J Ferlay, ISoerjomataram, MErviket al. GLOBOCAN 2012 v 1.0, Cancer Incidence and Mortality Worldwide. 2013. Lyon, International Agency for Research on Cancer. IARC CancerBase No. 11.
2. Evolution of the St. Gallen Consensus process for the optimal treatment of women with breast cancer;Coates;Breast,2015
3. Adjuvant exemestane with ovarian suppression in premenopausal breast cancer;Pagani;N Engl J Med,2014
4. Adjuvant ovarian suppression in premenopausal breast cancer;Francis;N Engl J Med,2015
5. Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy;Moore;N Engl J Med,2015